NEURAPTIVE THERAPEUTICS
Neuraptive was founded to commercialize innovative technology from the University of Texas. The company is dedicated to bringing this technology to patients. It develops novel therapeutics and medical products to address the unmet needs of physicians and patients impacted by peripheral nerve injuries. Its franchise therapeutics product is designed for administration during surgery to improve outcomes for patients impacted by acute nerve injury repairs and reconstructive surgical procedures involving peripheral nerves. Founded in 2016, Neuraptive Therapeutics is headquartered in Lafayette, Colorado.
NEURAPTIVE THERAPEUTICS
Industry:
Biotechnology Commercial Health Care Therapeutics
Founded:
2016-01-01
Address:
Lafayette, Colorado, United States
Country:
United States
Website Url:
http://www.neuraptive.com
Total Employee:
1+
Status:
Active
Contact:
1(303)736-9657
Email Addresses:
[email protected]
Total Funding:
12.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network Apache Sitelinks Search Box
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Current Advisors List
Current Employees Featured
Founder
Investors List
New Rhein
New Rhein investment in Series A - Neuraptive Therapeutics
Central Texas Angel Network
Central Texas Angel Network investment in Seed Round - Neuraptive Therapeutics
New Rhein
New Rhein investment in Seed Round - Neuraptive Therapeutics
Official Site Inspections
http://www.neuraptive.com Semrush global rank: 3.32 M Semrush visits lastest month: 4.87 K
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.171
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Neuraptive Therapeutics"
Home | Neuraptive
Neuraptive is developing novel therapeutics and medical products to address the unmet needs of physicians and patients impacted by peripheral nerve injuries.See details»
Company | Neuraptive
Neuraptive Therapeutics is a biotechnology company developing novel therapies to potentially improve outcomes in peripheral nerve injuries, or PNI.See details»
Patients - Neuraptive
Neuraptive is committed to developing safe and effective medicines to transform the lives of patients with serious or life-threatening peripheral nerve injuries. Our goal is to provide access …See details»
Neuraptive Therapeutics - Crunchbase Company …
Neuraptive Therapeutics is a medical technology company that brings novel products to patients with peripheral nerve injuries. Neuraptive was founded to commercialize innovative technology from the University of Texas.See details»
Neuraptive Therapeutics Announces Key …
Oct 24, 2022 · PHILADELPHIA-- ( BUSINESS WIRE )--Neuraptive Therapeutics, Inc., a biotechnology company dedicated to developing novel therapeutics and medical products to address the unmet needs of physicians...See details»
Neuraptive Therapeutics, Inc. Announces Appointment …
Nov 17, 2022 · Neuraptive Therapeutics, Inc. is a biotechnology company dedicated to developing novel therapeutics and medical products to address the unmet needs of physicians and patients impacted by...See details»
Robert S. Radie - CEO & Chairman at Neuraptive - The Org
Led multiple companies from development stage to commercialization or M&A.See details»
Neuraptive Therapeutics, Inc. Announces Achievement …
Jan 8, 2024 · WAYNE, Pa.-- ( BUSINESS WIRE )--Neuraptive Therapeutics, Inc., a leader in nerve repair and regeneration, is pleased to announce a significant milestone in transforming the treatment paradigm...See details»
Neuraptive Therapeutics Raises $19.5M, Expands …
Nov 2, 2022 · A Philadelphia biotechnology company working on therapeutics and medical products for patients impacted by peripheral nerve injuries has raised $19.5 million from private investors. The equity financing was disclosed in …See details»
Team - Neuraptive
Neuraptive's team has extensive experience in the biotechnology and pharmaceutical industry. The team is comprised of experts in the field of research and development, manufacturing, and commercialization.See details»
Neuraptive Therapeutics, Inc. Announces Achievement of Proof of …
WAYNE, Pa., January 08, 2024--Neuraptive Therapeutics, Inc., a leader in nerve repair and regeneration, is pleased to announce a significant milestone in transforming the treatment …See details»
Neuraptive Therapeutics, Inc., a biotech startup based in Colorado …
Dec 19, 2018 · Neuraptive was established to develop and commercialize novel nerve repair technologies to improve clinical outcomes for patients and the surgeons who care for them. …See details»
Neuraptive Therapeutics, Inc. Announces Positive 24-Week Data …
WAYNE, Pa., February 22, 2024 -- (BUSINESS WIRE)--Neuraptive Therapeutics, Inc., a pioneer in nerve repair and regeneration, is proud to announce new 24-week data from the ongoing …See details»
Neuraptive Therapeutics Receives FDA Breakthrough Therapy …
Sep 11, 2024 · Neuraptive is preparing to launch a Phase 3 pivotal program for NTX-001 in early 2025. The program will consist of a single randomized, double-blind, placebo-controlled study …See details»
Neuraptive Therapeutics - PitchBook
Developer of a therapeutic technology designed to improve the speed and quality of recovery from peripheral nerve injury.See details»
Clinical Trials - Neuraptive
Apr 28, 2020 · Take a look here for a more in-depth look about the conditions we treat, information on how to participate in a clinical trial, and a listing of our current trials.See details»
Neuraptive Therapeutics Inc. Receives Orphan Drug Designation …
Jan 15, 2024 · WAYNE, Pa.-- ( BUSINESS WIRE )--Neuraptive Therapeutics Inc., a leader in innovative medical solutions, is pleased to announce that it has received Orphan Drug …See details»
Bob Radie - Chairman of the Board and Chief Executive Officer ...
Bob Radie is the Chairman of the Board and Chief Executive Officer at Neuraptive Therapeutics. He previously worked as the President, CEO at Egalet. From November 2010 to October …See details»
VC-backed Neuraptive appoints Radie as CEO - Venture Capital …
Jun 23, 2020 · Neuraptive Therapeutics Inc, a developer of new treatments for peripheral nerve injuries, has named Robert S. Radie as CEO. Radie is the former CEO of Zyla Life Sciences …See details»
Technology - Neuraptive
Volunteers and Doctors who participate in clinical trials help make new therapies a reality. Clinical trials are carefully designed research studies in humans that evaluate the safety and efficacy …See details»